Thinking of joining a study?

Register your interest

NCT05558241 | Recruiting | Prostate Cancer


Micro-UltraSound In Cancer - Active Surveillance
Sponsor:

University of Alberta

Brief Summary:

This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.

Condition or disease

Prostate Cancer

Intervention/treatment

High-resolution micro-ultrasound

Phase

Not Applicable

Study Type : Interventional
Estimated Enrollment : 210 participants
Masking : None (Open Label)
Primary Purpose : Diagnostic
Official Title : Micro-UltraSound In Cancer - Active Surveillance (MUSIC-AS)
Actual Study Start Date : January 1, 2023
Estimated Primary Completion Date : December 31, 2025
Estimated Study Completion Date : June 30, 2026
Arm Intervention/treatment

Experimental: Combined MRI and micro-ultrasound guided prostate biopsy.

In a single biopsy session, first, a microUS-guided biopsy of regions of interest (ROIs) will be performed. The MRI fusion software will then be turned on, the clinician unblinded to the MRI results, and biopsy cores from within the boundaries of the MRI-fused lesion will be sampled from ROIs. Up to two ROIs identified on microUS or MRI will be targeted with up to 3 cores per ROI. If the MRI ROIs overlap with the microUS ROIs after unblinding, then the cores taken during the microUS-guided biopsy will be counted as both microUS and MRI-guided. Finally, a standard 12-core systematic biopsy will be performed.

Device: High-resolution micro-ultrasound

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Adult men with Gleason Grade Group 1 prostate cancer managed by active surveillance who require a confirmatory prostate biopsy
Exclusion Criteria
  • Men who cannot undergo a prostate MRI
  • Men who cannot undergo a prostate biopsy

Micro-UltraSound In Cancer - Active Surveillance

Location Details


Please Choose a site



Micro-UltraSound In Cancer - Active Surveillance

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

Canada, Alberta

Kipnes Urology Centre - Kaye Edmonton Clinic

Edmonton, Alberta, Canada, T6G1Z1

Loading...